Who Buys Sirolimus from India — 128 Importers Behind a $14.9M Market
India's sirolimus import market is served by 128 active buyers who collectively imported $14.9M across 1,244 shipments. EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) leads with a 48.1% market share, followed by ASCEND LABORATORIES,LLC and DR REDDYS LABORATORIES INC. The top 5 buyers together control 88.6% of total import value, reflecting a concentrated buyer landscape.
Top Sirolimus Importers — Ranked by Import Value
EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) is the leading sirolimus importer from India, holding a 48.1% share of the $14.9M market across 1,244 shipments from 128 buyers. The top 5 buyers — EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), ASCEND LABORATORIES,LLC (UNITED STATES), DR REDDYS LABORATORIES INC (UNITED STATES), ASCEND LABORATORIES LLC (UNITED STATES), XX RXXDYSXXABOXXTORXXS IXX (UNITED STATES) — collectively control 88.6% of total import value.
Top Sirolimus Buyers & Importers
Ranked by import value · 128 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICESUNITED STATES SIROLIMUS TABLETS 0.5 MG - 1 X 100PHARMA : SIROLIMUS TABLETS 0.5MG (SIROLISIROLIMUS TABLETS 0.5 MG - 1 X 100TBS | $7.2M | 5 | 48.1% |
| 2 | ASCEND LABORATORIES,LLCUNITED STATES SIROLIMUS TABLETS 0.5 MG - 1 X 100PHARMA : SIROLIMUS TABLETS 0.5MG (SIROLISIROLIMUS TABLETS 0.5 MG - 1 X 100TBS | $3.6M | 5 | 24.1% |
| 3 | DR REDDYS LABORATORIES INCUNITED STATES SIROLIMUS TABLETS 0.5 MG - 1 X 100PHARMA : SIROLIMUS TABLETS 0.5MG (SIROLISIROLIMUS TABLETS 0.5 MG - 1 X 100TBS | $1.2M | 5 | 8.4% |
| 4 | ASCEND LABORATORIES LLCUNITED STATES SIROLIMUS TABLETS 0.5 MG - 1 X 100PHARMA : SIROLIMUS TABLETS 0.5MG (SIROLISIROLIMUS TABLETS 0.5 MG - 1 X 100TBS | $646.6K | 5 | 4.3% |
| 5 | XX RXXDYSXXABOXXTORXXS IXXUNITED STATES SIROLIMUS TABLETS 0.5 MG - 1 X 100PHARMA : SIROLIMUS TABLETS 0.5MG (SIROLISIROLIMUS TABLETS 0.5 MG - 1 X 100TBS | $540.8K | 5 | 3.6% |
| 6 | SMALL ANIMAL CLINICAL SERVICESUNITED STATES SIROLIMUS TABLETS 0.5 MG - 1 X 100PHARMA : SIROLIMUS TABLETS 0.5MG (SIROLISIROLIMUS TABLETS 0.5 MG - 1 X 100TBS | $178.3K | 5 | 1.2% |
| 7 | EVERSANA LIFE SCIENCES SERVICESLLCUNITED STATES SIROLIMUS TABLETS 0.5 MG - 1 X 100PHARMA : SIROLIMUS TABLETS 0.5MG (SIROLISIROLIMUS TABLETS 0.5 MG - 1 X 100TBS | $165.0K | 5 | 1.1% |
| 8 | GLENMARK PHARMACEUTICALS INCUNITED STATES SIROLIMUS TABLETS 0.5 MG - 1 X 100PHARMA : SIROLIMUS TABLETS 0.5MG (SIROLISIROLIMUS TABLETS 0.5 MG - 1 X 100TBS | $156.9K | 5 | 1.1% |
| 9 | ASCEND LABORATORIESLLCUNITED STATES SIROLIMUS TABLETS 0.5 MG - 1 X 100PHARMA : SIROLIMUS TABLETS 0.5MG (SIROLISIROLIMUS TABLETS 0.5 MG - 1 X 100TBS | $128.6K | 5 | 0.9% |
| 10 | ASCEND LABORATORIES, LLC,UNITED STATES SIROLIMUS TABLETS 0.5 MG - 1 X 100PHARMA : SIROLIMUS TABLETS 0.5MG (SIROLISIROLIMUS TABLETS 0.5 MG - 1 X 100TBS | $102.8K | 5 | 0.7% |
| 11 | XXENMXXK PXXRMAXXUTIXXLS XXCUNITED STATES SIROLIMUS TABLETS 0.5 MG - 1 X 100PHARMA : SIROLIMUS TABLETS 0.5MG (SIROLISIROLIMUS TABLETS 0.5 MG - 1 X 100TBS | $57.3K | 5 | 0.4% |
| 12 | DEREK GRUBBIRELAND HEALTH CARE PRODUCT-RAPACAN, SIROLIMUS THEALTH CARE PRODUCT-SIROLIMUS TABLET 1MG | $54.2K | 5 | 0.4% |
| 13 | TRANS SPED AG - SMISWITZERLAND SIROMUS 1MG SIZE-6 TABS/PACKRAPACAN 1MG SIZE-10 TABS/PACSIROMUS 1MG SIZE-6 TABS/PACKS | $52.7K | 5 | 0.4% |
| 14 | ASCEND LABORATORIES SPACHILE SIROLIMUS TABLETS 0.5 MG - 1 X 100PHARMA : SIROLIMUS TABLETS 0.5MG (SIROLISIROLIMUS TABLETS 0.5 MG - 1 X 100TBS | $36.3K | 5 | 0.2% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Sirolimus — and from which countries?
Flow of Sirolimus exports from India: each country's share and the named importers behind the numbers
Sirolimus — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $14.5M through 116 shipments. This represents a market share of 97.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• EVERSANA LIFE SCIENCE SERVICES - $7.2M (49.4% of country's total business)
• ASCEND LABORATORIES,LLC - $3.6M (24.8% of country's total business)
• DR REDDYS LABORATORIES INC - $1.2M (8.6% of country's total business)
• ASCEND LABORATORIES LLC - $646.6K (4.5% of country's total business)
• XX RXXDYSXXABOXXTORXXS IXX - $540.8K (3.7% of country's total business)
• Rest of United States's importers - $1.3M (9.1% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $125.2K, indicating premium pricing strategy compared to the market average of $12.0K.
United States is a key market for Sirolimus imports, representing 97.5% of total trade value.
2Venezuela
Venezuela emerges as the second largest importing country, achieving a total trade value of $70.2K through 0 shipments. This represents a market share of 0.5% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Venezuela demonstrates strong market positioning with an average shipment value of $70.2K, indicating premium pricing strategy compared to the market average of $12.0K.
Venezuela is a key market for Sirolimus imports, representing 0.5% of total trade value.
3Switzerland
Switzerland emerges as the third largest importing country, achieving a total trade value of $62.7K through 404 shipments. This represents a market share of 0.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Switzerland has a diverse importer base, with their top importers including:
• TRANS SPED AG - SMI - $52.7K (84.0% of country's total business)
Key Insight: Switzerland demonstrates strong market positioning with an average shipment value of $155, indicating competitive pricing strategy compared to the market average of $12.0K.
Switzerland is a key market for Sirolimus imports, representing 0.4% of total trade value.
4Ireland
Ireland emerges as the fourth largest importing country, achieving a total trade value of $54.7K through 3 shipments. This represents a market share of 0.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Ireland has a diverse importer base, with their top importers including:
• DEREK GRUBB - $54.2K (98.9% of country's total business)
Key Insight: Ireland demonstrates strong market positioning with an average shipment value of $18.2K, indicating premium pricing strategy compared to the market average of $12.0K.
Ireland is a key market for Sirolimus imports, representing 0.4% of total trade value.
5Chile
Chile emerges as the fifth largest importing country, achieving a total trade value of $43.5K through 5 shipments. This represents a market share of 0.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Chile has a diverse importer base, with their top importers including:
• ASCEND LABORATORIES SPA - $36.3K (83.4% of country's total business)
Key Insight: Chile demonstrates strong market positioning with an average shipment value of $8.7K, indicating competitive pricing strategy compared to the market average of $12.0K.
Chile is a key market for Sirolimus imports, representing 0.3% of total trade value.
Buyer Segment Analysis
TransData Nexus Sirolimus buyer market intelligence
1Buyer Segment Analysis
The 128 buyers of Sirolimus from India can be categorized into several segments:
1. Distributors: Entities like EVERSANA LIFE SCIENCE SERVICES and ASCEND LABORATORIES, LLC, which account for significant portions of the total export value ($7.17M and $3.60M respectively), function as intermediaries. They procure Sirolimus in bulk and distribute it to healthcare providers, pharmacies, and other end-users. Their purchasing patterns typically involve large, regular orders to maintain a steady supply chain.
2. Contract Manufacturers: Companies such as DR. REDDY'S LABORATORIES INC. ($1.25M) and GLENMARK PHARMACEUTICALS INC. ($0.16M) likely import Sirolimus for further processing or formulation into finished pharmaceutical products. Their procurement is characterized by bulk purchases aligned with production schedules and market demand forecasts.
3. Hospital Groups and Clinical Services: Entities like SMALL ANIMAL CLINICAL SERVICES ($0.18M) may represent specialized healthcare providers or veterinary clinics that import Sirolimus directly for patient treatment. Their buying behavior is typically demand-driven, with orders placed as needed to meet patient requirements.
The repeat buyer rate of 60.9% indicates a stable demand and ongoing relationships between Indian exporters and these buyers, suggesting consistent quality and reliability in the supply chain.
Country-Specific Import Regulations
TransData Nexus Sirolimus buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Sirolimus from India, the import regulations are as follows:
1. United States:
2. Venezuela:
3. Switzerland:
4. Ireland:
5. Chile:
Demand Drivers & Market Opportunity
TransData Nexus Sirolimus buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Sirolimus in importing countries is driven by several factors:
1. Disease Prevalence: Sirolimus is primarily used as an immunosuppressant in organ transplantation. The increasing incidence of organ transplants globally fuels demand. For instance, in the United States, over 42,800 organ transplants were reported in 2022, indicating a substantial patient base requiring immunosuppressive therapy.
2. Government Healthcare Programs and Universal Health Coverage Expansion: Many countries are expanding healthcare access, leading to increased availability of essential medicines. Programs aimed at universal health coverage ensure that critical drugs like Sirolimus are accessible to a broader population, thereby driving demand.
3. WHO Essential Medicines List Procurement and Tender-Based Purchasing: Sirolimus is included in the World Health Organization's Essential Medicines List, guiding countries in prioritizing procurement. Many governments and international organizations conduct tender-based purchasing to acquire essential medicines, ensuring a steady demand for Sirolimus.
With 128 buyers across 48 countries, the market for Sirolimus imported from India demonstrates a diverse and sustained demand, influenced by these global health initiatives and the critical role of Sirolimus in transplant medicine.
Common Questions — Sirolimus Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest sirolimus buyer importing from India?
Based on import volume and value, EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) leads with $7.2M in imports and a 48.1% market share — the highest of any single sirolimus importer. ASCEND LABORATORIES,LLC (UNITED STATES) and DR REDDYS LABORATORIES INC (UNITED STATES) are the next largest buyers.
QHow many companies buy sirolimus from India?
There are 128 active sirolimus buyers importing from India, with a combined market of $14.9M across 1,244 shipments to 48 countries. The top 5 buyers hold 88.6% of total import value, while the remaining 123 buyers handle the other 11.4%.
QWhich countries import the most sirolimus from India?
The top importing countries for sirolimus from India are United States (97.5%), Venezuela (0.5%), Switzerland (0.4%), Ireland (0.4%), Chile (0.3%). These markets represent the largest demand centres for Indian pharmaceutical exports of sirolimus, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for sirolimus from India?
The average import transaction value for sirolimus from India is $12.0K, with an average unit price of $9.57 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Sirolimus buyer market intelligence
1Buyer Segment Analysis
The 128 buyers of Sirolimus from India can be categorized into several segments:
1. Distributors: Entities like EVERSANA LIFE SCIENCE SERVICES and ASCEND LABORATORIES, LLC, which account for significant portions of the total export value ($7.17M and $3.60M respectively), function as intermediaries. They procure Sirolimus in bulk and distribute it to healthcare providers, pharmacies, and other end-users. Their purchasing patterns typically involve large, regular orders to maintain a steady supply chain.
2. Contract Manufacturers: Companies such as DR. REDDY'S LABORATORIES INC. ($1.25M) and GLENMARK PHARMACEUTICALS INC. ($0.16M) likely import Sirolimus for further processing or formulation into finished pharmaceutical products. Their procurement is characterized by bulk purchases aligned with production schedules and market demand forecasts.
3. Hospital Groups and Clinical Services: Entities like SMALL ANIMAL CLINICAL SERVICES ($0.18M) may represent specialized healthcare providers or veterinary clinics that import Sirolimus directly for patient treatment. Their buying behavior is typically demand-driven, with orders placed as needed to meet patient requirements.
The repeat buyer rate of 60.9% indicates a stable demand and ongoing relationships between Indian exporters and these buyers, suggesting consistent quality and reliability in the supply chain.
Country-Specific Import Regulations
TransData Nexus Sirolimus buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Sirolimus from India, the import regulations are as follows:
1. United States:
2. Venezuela:
3. Switzerland:
4. Ireland:
5. Chile:
Demand Drivers & Market Opportunity
TransData Nexus Sirolimus buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Sirolimus in importing countries is driven by several factors:
1. Disease Prevalence: Sirolimus is primarily used as an immunosuppressant in organ transplantation. The increasing incidence of organ transplants globally fuels demand. For instance, in the United States, over 42,800 organ transplants were reported in 2022, indicating a substantial patient base requiring immunosuppressive therapy.
2. Government Healthcare Programs and Universal Health Coverage Expansion: Many countries are expanding healthcare access, leading to increased availability of essential medicines. Programs aimed at universal health coverage ensure that critical drugs like Sirolimus are accessible to a broader population, thereby driving demand.
3. WHO Essential Medicines List Procurement and Tender-Based Purchasing: Sirolimus is included in the World Health Organization's Essential Medicines List, guiding countries in prioritizing procurement. Many governments and international organizations conduct tender-based purchasing to acquire essential medicines, ensuring a steady demand for Sirolimus.
With 128 buyers across 48 countries, the market for Sirolimus imported from India demonstrates a diverse and sustained demand, influenced by these global health initiatives and the critical role of Sirolimus in transplant medicine.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 128 global importers of Sirolimus identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 1,244 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 48 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,244 Verified Shipments
128 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists